Key facts
- This page summarizes Paul Sagan's Form 4 filing for Moderna, Inc. (MRNA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Mar 2025, 16:24.
Paul Sagan - 03 Mar 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)
- Reporting relationship
- Director
- Issuer ticker
- MRNA
- Reported as of
- 03 Mar 2025
- Net transaction value
- +$1,004,251
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2025, 16:24:36 UTC
- Prior SEC filing
- 07 May 2024
- Next SEC filing
- 01 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Dillon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Paul Sagan filed Form 4 for Moderna, Inc. (MRNA) on 04 Mar 2025.
Change
- Previous filing in this sequence was filed on 07 May 2024.
- Current net transaction value: +$1,004,251.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRNA
transaction
Common Stock
Purchase
- Transaction value
- $1,004,251
- Shares
- +31,620
- Change %
- +11%
- Price
- $31.76
- Shares after
- 312,027
- Date
- 03 Mar 2025
- Ownership
- By: The Paul Sagan Revocable Trust
- Footnotes
- F1, F2
MRNA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 703
- Date
- 03 Mar 2025
- Ownership
- Direct
MRNA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 14,951
- Date
- 03 Mar 2025
- Ownership
- By: Erwin Park LLC
- Footnotes
- F3
MRNA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 166,452
- Date
- 03 Mar 2025
- Ownership
- By: The Chatham Trust
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.46 to $31.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Footnote F2
This balance reflects the transfer of 90,000 shares of the Issuer's common stock from The Paul Sagan Revocable Trust to The Chatham Trust on November 21, 2024.
Footnote F3
Erwin Park LLC is an investment vehicle owned by the Reporting Person's children. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.